(R)-5-(4-(2-(3,5-difluorophenyl)-2-hydroxyacetamido)-2-methylphenyl)-N-isopropyl-2-(methylamino)nicotinamide

ID: ALA4858598

PubChem CID: 156118288

Max Phase: Preclinical

Molecular Formula: C25H26F2N4O3

Molecular Weight: 468.50

Molecule Type: Unknown

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  CNc1ncc(-c2ccc(NC(=O)[C@H](O)c3cc(F)cc(F)c3)cc2C)cc1C(=O)NC(C)C

Standard InChI:  InChI=1S/C25H26F2N4O3/c1-13(2)30-24(33)21-10-16(12-29-23(21)28-4)20-6-5-19(7-14(20)3)31-25(34)22(32)15-8-17(26)11-18(27)9-15/h5-13,22,32H,1-4H3,(H,28,29)(H,30,33)(H,31,34)/t22-/m1/s1

Standard InChI Key:  RLQQJEXTCSZPIW-JOCHJYFZSA-N

Molfile:  

 
     RDKit          2D

 34 36  0  0  0  0  0  0  0  0999 V2000
    6.2885   -9.3523    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.2873  -10.1718    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.9954  -10.5808    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.7050  -10.1713    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.7022   -9.3487    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.9936   -8.9434    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.5827   -8.9440    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.5839   -8.1257    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.8769   -7.7174    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.1683   -8.1262    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.1712   -8.9476    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.8787   -9.3522    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.4631   -9.3599    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.7538   -8.9540    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.4662  -10.1771    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    8.4134  -10.5788    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    9.1205  -10.1691    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.8288  -10.5766    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.1192   -9.3519    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   10.5359  -10.1669    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.2429  -10.5757    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.9495  -10.1667    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.9487   -9.3486    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.2353   -8.9413    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.5317   -9.3527    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.6577  -10.5745    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   11.2312   -8.1241    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    9.8301  -11.3938    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.1754  -10.5830    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.1785  -11.4002    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.8816  -10.1718    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.5793  -10.5798    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.4600   -7.7187    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.4587   -6.9015    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  1  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
 12  7  1  0
  1  7  1  0
 13 14  2  0
 13 15  1  0
 11 13  1  0
  4 16  1  0
 16 17  1  0
 17 18  1  0
 17 19  2  0
 18 20  1  0
 20 21  2  0
 21 22  1  0
 22 23  2  0
 23 24  1  0
 24 25  2  0
 25 20  1  0
 22 26  1  0
 24 27  1  0
 18 28  1  1
 15 29  1  0
 29 30  1  0
 29 31  1  0
  2 32  1  0
 10 33  1  0
 33 34  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4858598

    ---

Associated Targets(Human)

EIF2AK3 Tchem Eukaryotic translation initiation factor 2-alpha kinase 3 (635 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
EIF2S1 Tchem Eukaryotic translation initiation factor 2 subunit 1 (143 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 468.50Molecular Weight (Monoisotopic): 468.1973AlogP: 4.19#Rotatable Bonds: 7
Polar Surface Area: 103.35Molecular Species: NEUTRALHBA: 5HBD: 4
#RO5 Violations: HBA (Lipinski): 7HBD (Lipinski): 4#RO5 Violations (Lipinski):
CX Acidic pKa: 12.01CX Basic pKa: 4.86CX LogP: 4.12CX LogD: 4.12
Aromatic Rings: 3Heavy Atoms: 34QED Weighted: 0.42Np Likeness Score: -1.16

References

1. Calvo V, Surguladze D, Li AH, Surman MD, Malibhatla S, Bandaru M, Jonnalagadda SK, Adarasandi R, Velmala M, Singireddi DRP, Velpuri M, Nareddy BR, Sastry V, Mandati C, Guguloth R, Siddiqui S, Patil BS, Chad E, Wolfley J, Gasparek J, Feldman K, Betzenhauser M, Wiens B, Koszelak-Rosenblum M, Zhu G, Du H, Rigby AC, Mulvihill MJ..  (2021)  Discovery of 2-amino-3-amido-5-aryl-pyridines as highly potent, orally bioavailable, and efficacious PERK kinase inhibitors.,  43  [PMID:33895276] [10.1016/j.bmcl.2021.128058]

Source